KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
70 hedge funds and large institutions have $93.9M invested in Chinook Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 29 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-20
Holders Change %
-22.22%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
14
Reduced
29
Closed
27
Calls
$29K
Puts
$25K
Net Calls
+$4K
Net Calls Change
-$593K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.98M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.53M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.41M |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$822K |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$625K |
